Evaluating follow- up and complexity in cancer clinical trials (EFACCT): an eDelphi study of research professionals’ perspectives.

Markham-Jones, Helene, Curtis, Ffion, Law, Graham, Bridle, Christopher, Boyle, Dorothy and Ahmed, Tanweer (2020) Evaluating follow- up and complexity in cancer clinical trials (EFACCT): an eDelphi study of research professionals’ perspectives. BMJ Open, 10 (2). 10:e034269. ISSN 2044-6055

Full content URL: http://dx.doi.org/10.1136/bmjopen-2019-034269

Documents
Evaluating follow-up and complexity in cancer clinical trials (EFACCT): an eDelphi study of research professionals’ perspectives
eDelphi study evaluating follow-up and complexity in cancer clinical trials: research professional perspectives.
[img]
[Download]
[img]
Preview
PDF (Publisher's manuscript)
EFACCT_Delphi_Professional_BMJ_e034269.full.pdf - Whole Document
Available under License Creative Commons Attribution-NonCommercial 4.0 International.

339kB
Item Type:Article
Item Status:Live Archive

Abstract

Objectives: To evaluate patient follow-up and complexity in cancer clinical trial delivery, using consensus methods to: (1) identify research professionals’ priorities, (2) understand localised challenges, (3) define study complexity and workloads supporting the development of a trial rating and complexity assessment tool (TRACAT).
Design: A classic eDelphi completed in three rounds, conducted as the launch study to a multiphase national project (evaluating follow-up and complexity in cancer clinical trials).
Setting: Multicentre online survey involving professionals at National Health Service secondary care hospital sites
in Scotland and England varied in scale, geographical location and patient populations.
Participants: Principal investigators at 13 hospitals across nine clinical research networks recruited 33 participants using pre-defined eligibility criteria to form a multidisciplinary panel.
Main outcome measures: Statements achieving a consensus level of 70% on a 7-point Likert-type scale and ranked trial rating indicators (TRIs) developed by research professionals.
Results: The panel developed 75 consensus statements illustrating factors contributing to complexity, follow-up intensity and operational performance in trial delivery, and specified 14 ranked TRIs. Seven open questions in the first
qualitative round generated 531 individual statements. Iterative survey rounds returned rates of 82%, 82% and 93%.
Conclusions: Clinical trials operate within a dynamic, complex healthcare and innovation system where rapid
scientific advances present opportunities and challenges for delivery organisations and professionals. Panellists highlighted cultural and organisational factors limiting the profession’s potential to support growing trial complexity
and patient follow-up. Enhanced communication, interoperability, funding and capacity have emerged as key
priorities. Future operational models should test dialectic Singerian-based approaches respecting open dialogue and
shared values. Research capacity building should prioritise innovative, collaborative approaches embedding validated
review and evaluation models to understand changing operational needs and challenges. TRACAT provides a mechanism for continual knowledge assimilation to improve decision-making.

Additional Information:To cite: Jones HM, Curtis F, Law G, et al. Evaluating follow-up and complexity in cancer clinical trials (EFACCT): an eDelphi study of research professionals’ perspectives. BMJ Open 2020;0:e034269. doi:10.1136/ bmjopen-2019-034269
Keywords:Complexity, Cancer clinical trials, Delphi study, Research delivery, Singerian Inquiry, Workforce Planning Tool
Subjects:L Social studies > L510 Health & Welfare
B Subjects allied to Medicine > B900 Others in Subjects allied to Medicine
Divisions:College of Social Science > Lincoln Institute of Health
Related URLs:
ID Code:40113
Deposited On:05 Mar 2020 14:30

Repository Staff Only: item control page